Literature DB >> 18376175

Effect of plasma and red blood cell transfusions on survival in patients with combat related traumatic injuries.

Philip C Spinella1, Jeremy G Perkins, Kurt W Grathwohl, Alec C Beekley, Sarah E Niles, Daniel F McLaughlin, Charles E Wade, John B Holcomb.   

Abstract

BACKGROUND: The amount and age of stored red blood cells (RBCs) are independent predictors of multiorgan failure and death in transfused critically ill patients. The independent effect of plasma transfusion on survival has not been evaluated. Our objective was to determine the independent effects of plasma and RBC transfusion on survival for patients with combat-related traumatic injuries receiving any blood products.
METHODS: We performed a retrospective review of 708 patients transfused at least one unit of a blood product at one combat support hospital between November 2003 and December 2004. Admission vital signs, laboratory values, amount of blood products transfused in a 24-hour period, and Injury Severity Score (ISS) were analyzed by multivariate logistic regression to determine independent associations with in-hospital mortality.
RESULTS: Seven hundred and eight of 3,287 (22%) patients admitted for traumatic injuries were transfused a blood product. Median ISS was 14 (range, 9-25). In-hospital mortality was 12%. Survival was associated with admission Glasgow Coma Scale score, SBP, temperature, hematocrit, base deficit, INR, amount of RBCs transfused, and massive transfusion. Each transfused FFP unit was independently associated with increased survival (OR: 1.17; 95% CI: [1.06-1.29]; p = 0.002); each transfused RBC unit was independently associated with decreased survival (OR: 0.86; [0.8-0.92]; p = 0.001). A subset analysis of patients (n = 567) without massive transfusion (1-9 RBC/FWB units) also revealed an independent association between each FFP unit and improved survival (OR: 1.22; 95% CI: [1.0-1.48]; p = 0.05) and between each RBC unit and decreased survival (OR: 0.77; [0.64-0.92]; p = 0.004).
CONCLUSION: For trauma patients transfused at least one unit of a blood product, FFP and RBC amounts were independently associated with increased survival and decreased survival, respectively. Prospective studies are needed to determine whether the early and increased use of plasma and decreased use of RBCs affect mortality for patients with traumatic injuries requiring transfusion.

Entities:  

Mesh:

Year:  2008        PMID: 18376175     DOI: 10.1097/TA.0b013e318160ba2f

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  47 in total

1.  Predictors of postoperative mortality of ruptured abdominal aortic aneurysm: a retrospective clinical study.

Authors:  Sang Dong Kim; Jeong Kye Hwang; Sun Cheol Park; Ji Il Kim; In Sung Moon; Jang Sang Park; Sang Seob Yun
Journal:  Yonsei Med J       Date:  2012-07-01       Impact factor: 2.759

2.  Creation, implementation, and maturation of a massive transfusion protocol for the exsanguinating trauma patient.

Authors:  Timothy C Nunez; Pampee P Young; John B Holcomb; Bryan A Cotton
Journal:  J Trauma       Date:  2010-06

3.  Cause and timing of death in massively transfused trauma patients.

Authors:  Michael W Cripps; Matthew E Kutcher; Aaron Daley; Ryan C McCreery; Molly D Greenberg; Leslie M Cachola; Brittney J Redick; Mary F Nelson; Mitchell Jay Cohen
Journal:  J Trauma Acute Care Surg       Date:  2013-08       Impact factor: 3.313

4.  Fresh frozen plasma lessens pulmonary endothelial inflammation and hyperpermeability after hemorrhagic shock and is associated with loss of syndecan 1.

Authors:  Zhanglong Peng; Shibani Pati; Daniel Potter; Ryan Brown; John B Holcomb; Raymond Grill; Kathryn Wataha; Pyong Woo Park; Hasen Xue; Rosemary A Kozar
Journal:  Shock       Date:  2013-09       Impact factor: 3.454

5.  Platelet transfusion increases risk for acute respiratory distress syndrome in non-massively transfused blunt trauma patients.

Authors:  George Kasotakis; Nichole Starr; Erek Nelson; Bedabrata Sarkar; Peter Ashley Burke; Daniel George Remick; Ronald Gary Tompkins
Journal:  Eur J Trauma Emerg Surg       Date:  2018-04-07       Impact factor: 3.693

Review 6.  Syndecan-1 restitution by plasma after hemorrhagic shock.

Authors:  Rosemary A Kozar; Shibani Pati
Journal:  J Trauma Acute Care Surg       Date:  2015-06       Impact factor: 3.313

7.  Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial.

Authors:  Jessica C Cardenas; Xu Zhang; Erin E Fox; Bryan A Cotton; John R Hess; Martin A Schreiber; Charles E Wade; John B Holcomb
Journal:  Blood Adv       Date:  2018-07-24

8.  Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial.

Authors:  Hunter B Moore; Ernest E Moore; Michael P Chapman; Kevin McVaney; Gary Bryskiewicz; Robert Blechar; Theresa Chin; Clay Cothren Burlew; Fredric Pieracci; F Bernadette West; Courtney D Fleming; Arsen Ghasabyan; James Chandler; Christopher C Silliman; Anirban Banerjee; Angela Sauaia
Journal:  Lancet       Date:  2018-07-20       Impact factor: 79.321

9.  Fibrinogen Protects Against Barrier Dysfunction Through Maintaining Cell Surface Syndecan-1 In Vitro.

Authors:  Feng Wu; Rosemary A Kozar
Journal:  Shock       Date:  2019-06       Impact factor: 3.454

10.  Efficacy of a high FFP:PRBC transfusion ratio on the survival of severely injured patients: a retrospective study in a single tertiary emergency center in Japan.

Authors:  Daisuke Kudo; Junichi Sasaki; Satoshi Akaishi; Satoshi Yamanouchi; Tomoaki Koakutsu; Tomoyuki Endo; Takeaki Sato; Ryosuke Nomura; Hironao Yuzawa; Michio Kobayashi; Yotaro Shinozawa; Shigeki Kushimoto
Journal:  Surg Today       Date:  2013-02-19       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.